The performance of these pharmaceutical companies today was somewhat divergent. Moderna got hit by the FDA, and the drop really hurts. Those who bought the dip during the post-market session now feel like turning off the screen and staying quiet... However, traditional giants like Gilead and AstraZeneca are instead surging ahead. Is this the real spring for "long-termists"? As for Intuitive Surgical, it's painfully expensive but just won't fall much—still a game for the rich. I often think, entrusting your life to drug companies and robots is quite trendy, but entrusting your account to them is a bit scary. I'll just keep holding my losing positions and add a little self-mockery.